Ligand Pharmaceuticals (LGND) EBITDA Margin (2010 - 2026)
Ligand Pharmaceuticals (LGND) recorded EBITDA Margin of 26.39% in Q2 2026, down 9.24 percentage points from 35.62% a year earlier and down 23.08 percentage points from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) EBITDA Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Ligand Pharmaceuticals' EBITDA Margin came in at 43.93% as of Jun 30, 2026, up 43.59 percentage points year-over-year; for FY2025, it was 27.89%, up 20.33 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -10.74 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 7.56% in FY2024 (-29.35 pp), 36.91% in FY2023 (+9.10 pp), 27.81% in FY2022 (-36.33 pp) and 64.14% in FY2021 (+25.50 pp).
- The Q2 2026 figure is the lowest quarterly EBITDA Margin since Q1 2025.
- On a year-over-year basis, EBITDA Margin rose in four of the last eight quarters, with an average year-over-year change of +12.37 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 110.01 percentage points in Q1 2026, against a drop of 107.96 percentage points in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 49.46% (Q1 2026), 36.97% (Q4 2025) and 54.74% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Ligand Pharmaceuticals | 6.26 Bn | 2.72 Bn | - | 26.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.39% |
| Mar 31, 2026 | 49.46% |
| Dec 31, 2025 | 36.97% |
| Sep 30, 2025 | 54.74% |
| Jun 30, 2025 | 35.62% |
| Mar 31, 2025 | -60.54% |
| Dec 31, 2024 | -2.36% |
| Sep 30, 2024 | 23.43% |
| Jun 30, 2024 | -24.67% |
| Mar 31, 2024 | 37.94% |
| Dec 31, 2023 | 19.78% |
| Sep 30, 2023 | 35.56% |
| Jun 30, 2023 | 28.49% |
| Mar 31, 2023 | 53.90% |
| Dec 31, 2022 | -17.79% |
| Sep 30, 2022 | 43.60% |
| Jun 30, 2022 | 43.75% |
| Mar 31, 2022 | 43.24% |
| Dec 31, 2021 | 90.17% |
| Sep 30, 2021 | 47.62% |
API Access
Ligand Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();